Claire Dawson
Dana-Farber Cancer Institute is a cancer treatment and research centre in Boston, Massachusetts. It is a principal teaching affiliate of Harvard Medical School and is a member of the DanaFarber/Harvard Cancer Center (DF/HCC). Dana-Farber has been ranked as one of the best cancer hospitals in the world by Newsweek and U.S. News & World Report. The institute is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and private foundations and individual contributions. Dana-Farber has a long history of breakthroughs in cancer care and research, including developing treatments for acute lymphocytic leukemia and Wilms' tumor.
| Characteristics | Values |
|---|---|
| Name | Dana-Farber Cancer Institute |
| Location | 450 Brookline Avenue, Boston, Massachusetts |
| Type | Cancer facility, Teaching hospital, Comprehensive Cancer Center |
| Affiliated Institutions | Brigham and Women's Hospital, Boston Children's Hospital, Harvard Medical School, Beth Israel Deaconess Medical Center |
| Rankings | #3 cancer hospital in the US, #6 cancer hospital in the US, #3 in the world for cancer |
| Employees | 4,855+ full-time and part-time workers, 529 faculty members, 6,500+ professional and support staff |
| Annual Revenue | $1,733,386,000 |
| Patient Visits | 523,425+ adult and pediatric patient visits, 548,000+ outpatient visits and infusion treatments |
| Clinical Trials | Involved in more than 1,000 clinical trials |
Explore related products
What You'll Learn
Brigham and Women's Hospital
The Dana-Farber Cancer Institute in Boston, Massachusetts, is a nationally ranked cancer facility with a long history of breakthroughs in cancer treatment and research. It is affiliated with Brigham and Women's Hospital, which has been recognised as one of the top cancer care facilities by US News & World Report for 23 consecutive years.
The inpatient hospital for Dana-Farber Cancer Institute was moved to Brigham and Women's Hospital in 1997, allowing more space for research, laboratories, and adult outpatient care. The move also facilitated the opening of the Yawkey Center for Cancer Care in 2011, providing additional outpatient facilities adjacent to the Smith Laboratories.
The association between Dana-Farber and Brigham and Women's Hospital has been instrumental in driving cancer research and treatment forward. Their collaboration has led to significant breakthroughs, contributing to the development of new treatments and improved cure rates for various forms of cancer.
Partners Healthcare: Beverly Hospital's Affiliation
You may want to see also
Explore related products
Boston Children's Hospital
Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a nationally ranked cancer facility and teaching hospital. It is affiliated with several hospitals, including Brigham and Women's Hospital, Boston Children's Hospital, and Massachusetts General Hospital.
The hospital has a large research enterprise, receiving the most funding from the National Institutes of Health (NIH) compared to any other children's hospital. This funding supports its extensive research staff, with 3,000 researchers and scientific staff members. Boston Children's Hospital also has a substantial clinical staff, including approximately 2,000 medical and dental professionals, 475 residents, fellows, and interns, and over 2,700 nurses.
The hospital is equipped with a regional pediatric intensive care unit and a level IV neonatal intensive care unit verified by the American Academy of Pediatrics. It is also an ACS-verified level I pediatric trauma center. Boston Children's Hospital is committed to providing positive experiences for patients and their families, offering various support services and resources.
Alcohol Detox: Hospital-Assisted Recovery
You may want to see also
Explore related products
Massachusetts General Hospital
The Dana-Farber Cancer Institute is a top-ranked cancer hospital in the United States, located in Boston, Massachusetts. It is recognised for its revolutionary discoveries and advancements in cancer treatment and research.
Dana-Farber is associated with several hospitals in the region, including Massachusetts General Hospital, Brigham and Women's Hospital, Boston Children's Hospital, and St. Elizabeth's Medical Center. These affiliations enable Dana-Farber to provide comprehensive care and collaborate on various cancer specialties.
The hospital has a long history of providing exceptional patient care, conducting groundbreaking research, and training future healthcare professionals. It is renowned for its multidisciplinary approach to healthcare, with various departments and centres of excellence working together to provide comprehensive treatment options. Mass General has a dedicated cancer centre, the Mass General Cancer Center, which is a leader in cancer research, treatment, and patient care.
The association between Dana-Farber and Massachusetts General Hospital allows patients to benefit from the expertise and resources of both institutions. They work together to provide state-of-the-art cancer treatment options, clinical trials, and supportive care services. This collaboration enhances the quality of cancer care available to patients in the region and contributes to advancements in cancer research and treatment approaches.
Additionally, Massachusetts General Hospital's strong academic affiliation with Harvard Medical School further strengthens the educational and research capabilities of Dana-Farber. This affiliation facilitates the exchange of knowledge, expertise, and resources, fostering a dynamic and innovative environment for cancer research and treatment.
Hospital Stay: A Patient's Experience and Insights
You may want to see also
Explore related products
Dana-Farber's inpatient hospital
Dana-Farber Cancer Institute is a cancer facility and teaching hospital located at 450 Brookline Avenue in Boston, Massachusetts. It is ranked among the best cancer hospitals in the world, with U.S. News ranking it as the third-best cancer hospital in the United States. Dana-Farber has a long history of breakthroughs in cancer care and research, including developing treatments for acute lymphocytic leukemia and Wilms' tumor, common cancers in children.
The inpatient hospital at Dana-Farber is located within Brigham and Women's Hospital, a top-ranked cancer care facility. In 2023, Dana-Farber announced a partnership with Beth Israel Deaconess Medical Center to build a standalone inpatient hospital focused on treating adult cancer patients.
The inpatient hospital at Dana-Farber has special air filter systems installed to protect patients from infection, and latex balloons are prohibited to safeguard latex-sensitive patients and staff. Fresh flowers and living plants are also not allowed due to infection control measures. Nutrition is a key aspect of inpatient care, and patients are offered a variety of snacks between meals and throughout the night to meet their individual needs.
Dana-Farber is a Comprehensive Cancer Center designated by the National Cancer Institute and an affiliate of Harvard Medical School. It is also a founding member of the DanaFarber/Harvard Cancer Center (DF/HCC), a research consortium that is one of the federally designated Comprehensive Cancer Centers. Dana-Farber employs thousands of staff and sees approximately 500,000 to 550,000 patient visits annually, with over 1,000 clinical trials underway.
Inova Fairfax Hospital: Fairfax County's Top Medical Center
You may want to see also
Dana-Farber's outpatient hospital
Dana-Farber Cancer Institute is a top-ranked cancer hospital in Boston, Massachusetts. It is recognised as one of the world's best cancer hospitals, ranked #3 in oncology by Newsweek in 2022. The institute is also ranked #6 in the US as of 2024.
Dana-Farber has a long history of breakthrough discoveries in cancer care and research. It is a Comprehensive Cancer Centre, as designated by the National Cancer Institute, and is a principal teaching affiliate of Harvard Medical School. The institute conducts community-based programs in cancer prevention, detection, and control in New England, and maintains joint programs with other Boston institutions, including St. Elizabeth's Medical Center, Brigham and Women's Hospital, Boston Children's Hospital, and Massachusetts General Hospital.
The Yawkey Center for Cancer Care, which provides outpatient facilities, was opened in 2011 adjacent to the Smith Laboratories. Dana-Farber sees approximately 548,000 outpatient visits per year. For visiting outpatients, there is an Outpatient Visitor Policy to adhere to. For example, fresh flowers and living plants are not allowed in the inpatient hospital due to the special air filter systems in place to protect patients from infection.
Dana-Farber is a member of the Multiple Myeloma Research Consortium and a founding member of the DanaFarber/Harvard Cancer Center (DF/HCC), a research consortium that is one of the 39 federally designated Comprehensive Cancer Centers. The institute is also a federally designated Center for AIDS Research.
Nadal's Wife Hospitalized: What We Know So Far
You may want to see also
Frequently asked questions
The Dana-Farber Cancer Institute is a cancer facility and teaching hospital located in Boston, Massachusetts. It is ranked among the best cancer hospitals in the world.
The Dana-Farber Cancer Institute has been affiliated with Brigham and Women's Hospital, Boston Children's Hospital, and Massachusetts General Hospital. In 2023, Dana-Farber announced a partnership with Beth Israel Deaconess Medical Center to build a standalone inpatient hospital for adult cancer patients.
The Dana-Farber Cancer Institute is known for its advancements in cancer treatment and research. It is a Comprehensive Cancer Center designated by the National Cancer Institute and an affiliate of Harvard Medical School. Dana-Farber has a long history of breakthrough discoveries, including developing treatments for acute lymphocytic leukemia and Wilms' tumor.
